Nature CommunicationsEvolutionary BiologyPeer-reviewed journal article
Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope
Florian BuchholziD, Lina M. UpterworthiD, Leif TüeffersiD, Espen Elias GrothiD, Kira Haas, Daniel Schütz, Abigail Savietto, Aditi BatraiD, Surajit Pal, Samarpita Banerjee, Badri N. DubeyiD, Sören FranzenburgiD, Barbara KalsdorfiD, Klaus Friedrich RabeiD, Dennis NurjadiiD, Jan RuppiD, Dan I. AnderssoniD, Holger SondermanniD, Marc BramkampiD, Roderich RoemhildiD, Hinrich Schulenburg YiD
Abstract
Antibiotic combination in time and space is a key strategy to combat antimicrobial resistance. The success of such treatment designs requires their robust efficacy across treatment conditions and a pathogens genomic diversity. This study found that an initial treatment with a {beta}-lactam antibiotic causes robust cellular sensitization towards an aminoglycoside antibiotic across the high-risk human pathogen Pseudomonas aeruginosa, including resistant strains. This phenomenon of cellular sensitization, termed negative hysteresis, is modulated by the Cpx envelope stress response system and linked to membrane stress during growth. The increase in efficacy is achieved through a {beta}-lactam induced elevated cellular uptake of the subsequently administered aminoglycoside. Negative hysteresis and the Cpx system are linked in several cases to the expression of synergistic drug interactions, thus enhancing efficacy of antibiotic combinations. Overall, our study identifies the phenomenon of negative hysteresis as a robustly inducible phenotype and thus a unique focus for optimizing antimicrobial therapy.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 2
- FWCI
- 7.91
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa
C. Barbosa, R. Roemhild, … H. Schulenburg·bioRxiv·Mar 9, 2019
- The effects of antibiotic combination treatments on Pseudomonas aeruginosa tolerance evolution and coexistence with Stenotrophomonas maltophilia
J. P. Law, A. J. Wood, V.-P. Friman·bioRxiv·Mar 25, 2022
- Collateral effects of bacteriophage resistance on antibiotic sensitivity in Pseudomonas aeruginosa
Laura R. Baars, Karsten Nagel, … J. G. Coen van Hasselt·bioRxiv·Oct 16, 2026
- In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA)
David Lasry, Luke B. Harrison, … Alexander Lawandi·Journal of Antimicrobial ChemotherapyPeer-reviewed·May 5, 2026
- Evaluating mono and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the Hollow-Fiber Infection Model
M. L. Avent, K. L. McCarthy, … J. A. Roberts·bioRxiv·Dec 23, 2021
- The Novel Silver-Containing Antimicrobial Potentiates Aminoglycoside Activity Against Pseudomonas aeruginosa.
G. Y. Donkor, G. M. Anderson, … J.-U. Dahl·bioRxiv·Mar 15, 2023